Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
YEDIOTH AHRONOTH CITES ISRAELI OFFICIAL SAYING PROPOSED US-IRAN DEAL WOULD LIMIT URANIUM ENRICHMENT FOR ONLY 15 YEARS
2026-05-07
YEDIOTH AHRONOTH CITES ISRAELI OFFICIAL SAYING PROPOSED US-IRAN DEAL WOULD LIMIT URANIUM ENRICHMENT FOR ONLY 15 YEARS
Back
Other News
2026-05-07
[Warner Pharmaceuticals: Subsidiary Receives Approval for Marketing Application of Beraprost Sodium] Warner Pharmaceuticals announced that its wholly-owned subsidiary, Hunan Warner Pharmaceutical Chiral Drug Co., Ltd., received the "Approval Notice f
[Warner Pharmaceuticals: Subsidiary Receives Approval for Marketing Application of Beraprost Sodium] Warner Pharmaceuticals announced that its wholly-owned subsidiary, Hunan Warner Pharmaceutical Chiral Drug Co., Ltd., received the "Approval Notice for Marketing Application of Beraprost Sodium as a Chemical Raw Material" (Notice No.: 2026YS00386) issued by the National Medical Products Administration (NMPA), and has been publicized on the "Registration Information of Raw Materials, Excipients and Packaging" platform of the Center for Drug Evaluation (CDE) of the NMPA. Beraprost sodium is the raw material for beraprost sodium tablets. Beraprost sodium tablets are mainly used to improve symptoms such as ulcers, intermittent claudication, pain and coldness caused by chronic arterial occlusive disease.
2026-05-07
Shell's CFO: The stock is still undervalued.
Shell's CFO: The stock is still undervalued.
Chat with us
, powered by
LiveChat